Lifeward (LFWD) vs Regentis Biomaterials (RGNT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Lifeward is the larger company by market cap ($18.2 million vs $11.9 million), about 1.5 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | LFWD | RGNT |
|---|---|---|
| Share price | $6.43 | $1.70 |
| Market cap | $18.21M | $11.94M |
| 1-day change | -1.08% | +4.29% |
| YTD return | -7.13% | -74.78% |
| 1-year return | -35.29% | — |
| 5-year return | -94.37% | — |
| EPS (TTM) | $-15.73 | $-2.46 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $9.84 | $15.50 |
| 52-week low | $4.14 | $1.23 |
| Distance from 52-week high | -34.65% | -89.03% |
| Analyst consensus | none | none |
| Avg. price target upside | +211.04% | +488.24% |
| Average volume | 6.08K | 76.78K |
| Shares outstanding | 2.83M | 7.02M |
| Employees | 81 | — |
| Sector | Health Care | Health Care |
| Industry | Industrial Specialties | Industrial Specialties |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Lifeward
LFWD stock →Lifeward Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, Germany, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices for individuals with spinal cord injury; ReStore Exo-Suit, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals' post-stroke.
Health Care · Industrial Specialties · 81 employees
About Regentis Biomaterials
RGNT stock →Regentis Biomaterials Ltd., a regenerative medicine company, develops and commercializes tissue repair solutions in the United States. It offers Gelrin, a platform based on hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen for the treatment and regeneration of damaged or diseased tissue; and GelrinC, a cell-free and off-the-shelf hydrogel, which is in Phase II clinical trial for the treatment of cartilage injuries in the knee.
Health Care · Industrial Specialties
LFWD vs RGNT FAQ
Which is bigger, Lifeward or Regentis Biomaterials?
Lifeward (LFWD) is larger, with a market capitalization of $18.21M compared with $11.94M for Regentis Biomaterials (RGNT).
Are Lifeward and Regentis Biomaterials in the same industry?
Yes. Both are classified in the Industrial Specialties industry within the Health Care sector.